DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Lantus (Insulin Glargine) - Current Clinical Trials

 
 



Lantus Related Clinical Trials

Conversion of Hyperglycemic Patients Being Treated With Intravenous Insulin Infusions to Lantus Insulin [Completed]

Insulin Glargine "All to Target" Trial [Completed]

Glycemic Effects of Morning Only, Evening Only or Twice Daily Insulin Glargine in Patients With Type 1 Diabetes [Not yet recruiting]

The Effect of Exenatide Compared to Lantus Insulin on Vascular Function in Type 2 Diabetes [Completed]

Insulin Glargine in Type I Diabetes Mellitus> Main Study "AT.LANTUS": A Trial Comparing Lantus Algorithms to Achieve Normal Blood Glucose Targets in Subjects With Uncontrolled Blood Sugar. Sub-study: "HALT"(Hypoglycaemia Avoidance With Lantus Trial) [Completed]

Glargine Dosing in Hospitalized Patients With Type 2 Diabetes and Renal Insufficiency [Recruiting]

A Study to Compare LY2963016 to Lantus After a Single Dose to Participants With Type 1 Diabetes Mellitus [Completed]

A Trial Comparing Lantus Algorithms to Achieve Normal Blood Glucose Targets in Subjects With Uncontrolled Blood Sugar With Type 2 Diabetes Mellitus [Completed]

Efficacy/Safety Study of Amaryl®M 1/500 mg Twice Daily Versus Amaryl® 4 mg Both in Combination With Lantus® in Type 2 Diabetes Mellitus [Completed]

Perioperative Insulin Glargine Dosing Study [Completed]

Establishing Cardiovascular Biomarkers to Define Preferred Lantus® Use [Recruiting]

Insulin Glargine at Bedtime or in AM Versus NPH [Completed]

Single Dose Clamp Study To Compare Concentration/Time Profile And Metabolic Activity Profile Of 2 New Formulations Of Insulin Glargine With Lantus [Completed]

Non-inferiority Study to Compare the Efficacy and Safety of Mylan's Insulin Glargine With Lantus® in Type 2 Diabetes Mellitus Patients (INSTRIDE 2) [Active, not recruiting]

Patient Preference and Satisfaction With Insulin Glargine (Lantus) Solostar Pen vs Conventional Vial-Syringe Method of Lantus Injection Therapy in Patients With Type 2 Diabetes Mellitus [Completed]

Non-inferiority Study to Compare the Efficacy and Safety of Mylan's Insulin Glargine With Lantus� in Type 1 Diabetes Mellitus Patients (INSTRIDE 1) [Active, not recruiting]

A Study of LY2963016 in Healthy Participants [Completed]

A Study to Compare LY2963016 and US-approved Lantus® After Single Dose Administration to Healthy Participants [Completed]

6-month Comparison of Morning Lantus Versus Neutral Protamine Hagedorn Insulin in Young Children With Type 1 Diabetes [Completed]

Can Insulin Glargine Improve Myocardial Function in Patients With T2D and Coronary Artery Disease (CAD) [Active, not recruiting]

Beta Cell Relieving and Cardiovascular Protective Effects of LANTUS Treatment in Type 2 Diabetes Patients [Completed]

Glargine Insulin vs.Continuous Regular Insulin in Diabetic Surgical Patients Receiving Total Parenteral Nutrition [Recruiting]

Comparison of a New Formulation of Insulin Glargine With Lantus® in Japanese Patients With Type 1 Diabetes Mellitus [Completed]

Lantus Versus Humalog Mix as add-on Therapy in Type Diabetes Patients Failing Sulfonylurea and Metformin Combination Treatment [Completed]

Insulin Glargine Benefits in Japanese Pts Outside of Japan (US or Brazil) [Completed]

JanUmet Before Insulin Lantus In Eastern Population Evaluation Program (JUBILEE) In Type 2 Diabetic Patients [Completed]

The ORIGIN Trial (Outcome Reduction With Initial Glargine Intervention) [Completed]

Characteristics of Glargine in Type 2 Diabetics [Completed]

A Study of LY2963016 Compared to LANTUS® in Adult Participants With Type 2 Diabetes Mellitus [Recruiting]

Adjunctive Therapy of Exenatide or Sitagliptin to Insulin Glargine in Type 2 Diabetes [Completed]

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus on Basal Plus Mealtime Insulin [Completed]

Sitagliptin Therapy in Hospitalized Patients With Type 2 Diabetes [Recruiting]

Efficacy and Safety of Insulin Glargine Versus. Neutral Protamine Hagedorn (NPH) Insulin in Children With Type 1 Diabetes Above 6 Years Old. [Completed]

Comparison of a New Formulation of Insulin Glargine With Lantus® Both in Combination With Oral Antihyperglycemic Drug(s) in Japanese Patients With Type 2 Diabetes Mellitus [Completed]

Effect of NPH Insulin, Insulin Detemir and Insulin Glargine on GH-IGF-IGFBP Axis [Completed]

Efficacy and Safety of Insulin Glargine/Lixisenatide Fixed Combination Versus Insulin Glargine Alone on Top of Metformin in Type 2 Diabetic Patients [Completed]

Lispro Mix 25 vs. Glargine in Type 2 Diabetics [Completed]

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus [Completed]

Insulin Detemir Compared to Insulin Glargine: Appetite and Calories Consumed in Type 1 Diabetes [Completed]

Glargine Versus NPH in Patients With Chronic Kidney Disease [Recruiting]

Single Dose Study With a New Insulin Glargine Formulation and Lantus® in Japanese Patients With Type 1 Diabetes Mellitus [Completed]

PK/PD Study of Gan & Lee's Insulin Glargine Injection in Comparison to Lantus in Type 1 Diabetes [Not yet recruiting]

Lantus in Prediabetes [Completed]

A Trial to Compare the Pharmacodynamic and Pharmacokinetic Properties of Biochaperone® Combo With Humalog® Mix25 and With Simultaneous Injections of Humalog® and Lantus® in Subjects With Type 2 Diabetes [Recruiting]

Insulin Glargine Versus Twice-Daily NPH [Completed]

Better Acceptance of Single Injection Apidra Added to Once Daily Lantus Versus Twice Daily Premixed Insulin in Real Life Use Setting [Terminated]

Comparison Safety and Efficacy of Basal Insulin Lantus® (Insulin Glargine) vs NPH Insulin in Combination With Oral Antidiabetic Drugs (OADs) in Patients With Diabetes Mellitus, Type 2 (DMT2) [Completed]

Efficacy Assessment of Insulin Glargine Versus LiraglutidE After Oral Agents Failure [Completed]

Safety and Efficacy of Technosphere® Insulin Inhalation Powder and Lantus® Compared to Humalog® and Lantus® Over 16-Weeks [Terminated]

Insulin Glargine, INITIATE Metabolic and Economic Outcomes of Lantus [Completed]

The Inova Type 2 Diabetes Mellitus Study [Not yet recruiting]

Comparison Study of Insulin Glargine and NPH Insulin [Enrolling by invitation]

Pioglitazone vs. Insulin Glargine in the Treatment of Secondary Drug Failure in Type 2 Diabetes [Completed]

Exenatide Compared With Insulin Glargine to Change Liver Fat Content in Type 2 Diabetes [Not yet recruiting]

The LANCET Trial: A Trial of Long-acting Insulin Injection to Reduce C-reactive Protein in Patients With Type 2 Diabetes [Terminated]

Endothelial Effects of Basal Insulin: Detemir Versus Glargine [Completed]

Insulin Glulisine Administered Pre-meal Versus Post-meal in Adult Subjects With Type 2 Diabetes Mellitus Receiving Insulin Glargine as Basal Insulin [Completed]

Combination of Sulfonylureas and Insulin Glargine Outpatient Therapy for Unstable Diabetes and Impending DKA [Completed]

Impact of Combined of Lantus(Insulin Glargine) and Lyxumia (Lixisenatide) on Insulin Secretion and Gastric Emptying [Completed]

Cost Effectiveness of Glargine Insulin Versus NPH Insulin [Completed]

A Study to Compare the Pharmacokinetics and Pharmacodynamics of LY2963016 to Lantus in Healthy Participants [Completed]

Simplified Insulin Protocol Using Lantus in Elderly [Active, not recruiting]

Euglycemic Clamp Dose-response Study Comparing a New Insulin Glargine Formulation With Lantus® [Completed]

Efficacy and Safety of Basal Insulin Glargine Combination With Exenatide Bid vs Aspart30 in T2DM [Not yet recruiting]

Efficacy and Safety of a Glargine-based Hospital Discharge Algorithm in Coronary Artery Bypass Graft(CABG) Patients [Active, not recruiting]

A Clinical Trial Comparing the Efficacy and Safety of Exubera® and Lantus® [Completed]

Evaluation of Insulin Glargine Versus Sitagliptin in Insulin-naive Patients [Completed]

24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine [Completed]

Assessment of Duration of Metabolic Effect of a Single Bolus of sc Injected Lantus Compared to NPH Insulin in Patients With Type 2 Diabetes [Completed]

Comparing Long-acting Insulins During Exercise in Type 1 Diabetes [Recruiting]

Liraglutide Hospital Discharge Trial [Recruiting]

Effect of Lantus and Apidra in Patients With Acute ST Elevation Myocardial Infarction [Terminated]

Effect of AC2993 Compared With Insulin Glargine in Patients With Type 2 Diabetes Also Using Combination Therapy With Sulfonylurea and Metformin [Completed]

Effects of Exenatide and Insulin Glargine in Subjects With Type 2 Diabetes [Completed]

Comparison of Neutral Protamine Hagedorn (NPH) and Lantus Based Insulin Regimen in the Management of Hypoglycemia in the Hospitalized Patients in Noncritical Care Setting [Active, not recruiting]

Determine Whether Glycemic Control is Different Between Lantus & a 3rd Oral Agent When Failure With Other Treatment [Completed]

LAPAS Study: Insulin Glargine in Type 2 Diabetes Mellitus [Completed]

20 Week Bridging Study in Type II DM [Completed]

Effectiveness of Subcutaneous Glargine On The Time To Closure of The Anion Gap in Patients Presenting to the Emergency Department With Diabetic Keto-acidosis [Completed]

Phenotype Evaluation in Insulin Naive Patients Using Lantus (Insulin Glargine) [Completed]

A Trial Comparing Two Therapies: Basal Insulin/Glargine, Exenatide and Metformin Therapy (BET) or Basal Insulin/Glargine, Bolus Insulin Lispro and Metformin Therapy (BBT) in Subjects With Type 2 Diabetes [Completed]

A Study of LY2605541 and Glargine and Exercise in Participants With Type 1 Diabetes [Completed]

Insulin Glargine Plus Insulin Glulisine Multiple Daily Injections (MDI) Versus Premix Insulin Treatment in Subjects With Diabetes Mellitus (Type 1 or Type 2) [Completed]

Linagliptin Inpatient Trial [Recruiting]

Chronic Reduction of Fasting Glycaemia With Insulin Glargine Improves First and Second Phase Insulin Secretion in Patients With Type 2 Diabetes [Completed]

Efficacy Study of Liraglutide vs.Sitagliptin vs. Glargine on Liver Fat in T2DM Subjects [Recruiting]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015